The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Omar Abdel-Wahab, Andrea Ablasser, Christina Curtis named winners of MSK’s 2025 Paul Marks Prize for Cancer Research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Omar Abdel-Wahab

Andrea Ablasser

Christina Curtis

Omar Abdel-Wahab, Andrea Ablasser, and Christina Curtis were named awardees of the 2025 Memorial Sloan Kettering Cancer Center Paul Marks Prize for Cancer Research. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

How next generation sequencing is powering the shift to more accessible—and comprehensive—cancer care

Research has shown that delivering tumor profiling results to cancer patients prior to initiation of treatment and connecting patients harboring an actionable oncogenic mutation with the right targeted therapy can deliver superior patient outcomes. To fulfill this promise of precision medicine, we need to ensure more targeted therapies are available to patients who need them. Fortunately, this work is well underway. xxx:more
By Kathy Davy
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account